SLC5A2 and acute kidney injury: Moreover, when comparing different renal function subgroups with eGFR of ≥90 mL/min/1.73 m2 among the three SGLT2 inhibitor user groups and non-users, we found that the lower their eGFR, the higher was their AKI-related hospitalization rates (Figure 8).